v3.26.3
Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA $ 29,769 $ 32,533 $ 74,236 $ 80,940
Interest expense, net 5,889 4,681 17,638 13,137
Depreciation and amortization 13,172 12,941 39,938 64,243
Share-based compensation and long-term incentive plan expense 6,969 7,181 21,552 21,474
Foreign exchange impact 744 571 2,390 (3,224)
SeaSpine merger-related costs 412 126 915 6,142
Restructuring costs and impairments related to M6 product lines 464 6 1,802 15,485
Strategic investments 509 227 2,093 4,094
Acquisition-related fair value adjustments 1,396 (427) 3,014 (1,800)
Interest and loss on investments   (10) (16) (41)
Litigation and investigation costs 301 21,548 5,402 28,619
Employee Retention Credit   (0) (951) (2,854)
Employee transition costs 1,428   3,170  
Loss before income taxes (5,248) (22,262) (41,079) (88,618)
Global Spine [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 26,783 30,642 72,773 76,591
Global Limb Reconstruction [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 2,986 1,891 1,463 4,349
Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 207,862 205,634 615,503 602,401
Non-GAAP Cost of sales 60,791 56,627 177,473 168,162
Non-GAAP Sales, general, and administrative 114,842 113,667 356,144 339,285
Non-GAAP Research and development 14,003 13,815 43,010 42,726
Other segment expenses 256 2,186 1,536 8,924
Non-GAAP Depreciation, amortization, and share-based compensation expense 11,799 13,194 36,896 37,636
Operating Segments [Member] | Global Spine [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 171,449 172,063 508,544 505,723
Non-GAAP Cost of sales 47,037 44,016 134,440 131,414
Non-GAAP Sales, general, and administrative 95,150 93,288 294,163 282,995
Non-GAAP Research and development 10,840 11,051 33,765 34,436
Other segment expenses 82 2,223 404 9,130
Non-GAAP Depreciation, amortization, and share-based compensation expense 8,443 9,157 27,001 28,843
Operating Segments [Member] | Global Limb Reconstruction [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 36,413 33,571 106,959 96,678
Non-GAAP Cost of sales 13,754 12,611 43,033 36,748
Non-GAAP Sales, general, and administrative 19,692 20,379 61,981 56,290
Non-GAAP Research and development 3,163 2,764 9,245 8,290
Other segment expenses 174 (37) 1,132 (206)
Non-GAAP Depreciation, amortization, and share-based compensation expense 3,356 4,037 9,895 8,793
Corporate, Non-Segment [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA $ 3,733 $ 7,951 $ 18,368 $ 24,283